🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
14/12/2022 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/09/2012 41,76 42,12 41,69 42,06 +0,18% 1,03% 7.895.632
17/09/2012 41,49 41,98 41,49 41,98 +0,87% 1,20% 11.538.899
14/09/2012 42,51 42,51 41,45 41,62 -2,33% 2,49% 17.331.195
13/09/2012 42,06 42,66 41,99 42,61 +0,29% 1,59% 12.429.175
12/09/2012 42,32 42,53 42,28 42,49 +0,45% 0,59% 9.378.028
11/09/2012 42,32 42,53 42,25 42,30 +0,16% 0,65% 8.975.596
10/09/2012 41,96 42,35 41,88 42,23 +0,48% 1,11% 9.427.284
07/09/2012 42,40 42,40 41,91 42,03 -0,43% 1,17% 8.738.538
06/09/2012 41,65 42,23 41,62 42,21 +1,84% 1,47% 10.349.419
05/09/2012 41,40 41,54 41,11 41,45 +0,44% 1,04% 8.734.870
04/09/2012 41,16 41,40 40,91 41,27 +0,46% 1,21% 25.771.368
31/08/2012 41,35 41,58 40,94 41,08 -0,16% 1,55% 28.906.355
30/08/2012 40,90 41,29 40,69 41,15 +0,14% 1,47% 8.964.173
29/08/2012 40,98 41,26 40,73 41,09 +0,54% 1,28% 7.973.289
28/08/2012 41,00 41,16 40,79 40,87 -0,51% 0,91% 8.419.842
27/08/2012 41,01 41,26 40,88 41,08 -0,16% 0,93% 8.122.943
24/08/2012 40,69 41,35 40,69 41,15 +0,75% 1,62% 10.649.252
23/08/2012 40,94 41,01 40,66 40,84 -0,26% 0,86% 10.531.876
22/08/2012 40,98 41,11 40,84 40,94 -0,07% 0,65% 9.025.900
21/08/2012 41,51 41,75 40,94 40,97 -1,85% 1,93% 11.281.615
20/08/2012 41,36 41,79 41,26 41,75 +0,95% 1,29% 9.150.612
17/08/2012 42,02 42,02 41,12 41,36 -1,37% 2,16% 15.549.071
16/08/2012 42,00 42,14 41,84 41,93 -0,27% 0,70% 8.798.903
15/08/2012 42,23 42,35 41,98 42,04 -0,79% 0,86% 7.808.229
14/08/2012 42,46 42,60 42,25 42,38 -0,02% 0,81% 6.572.742
13/08/2012 42,54 42,57 42,22 42,39 -0,34% 0,81% 8.943.318
10/08/2012 41,97 42,53 41,95 42,53 +0,65% 1,39% 9.736.025
09/08/2012 41,88 42,29 41,70 42,25 +0,50% 1,41% 10.466.586
08/08/2012 41,97 42,24 41,82 42,04 +0,14% 1,00% 11.308.968
07/08/2012 42,50 42,51 41,97 41,98 -1,10% 1,28% 11.407.899